SCORPIA DOYLE: Open Payments
NPI 1548045826 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 7 payments from 6 companies in 2025. Trend: 2023 $491 · 2024 $60 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $255 |
| Neurocrine BioSciences, Inc. | 1 | $175 |
| Gilead Sciences, Inc. | 1 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $104 |
| Boston Scientific Corporation | 1 | $50 |
| Braeburn Inc. | 1 | $27 |
Products named: INGREZZA, EVENITY, Epclusa, CAPLYTA, APOLLO ESG System, BRIXADI.
Industry payments across IL — which companies pay providers there.
